APOLLOHOSPNSEQ4 FY26May 20, 2026

Apollo Hospitals Enterprise Limited

6,626words
4turns
0analyst exchanges
0executives
Key numbers — 40 extracted
rs,
osPITALS May 20, 2026 The Secretary, Bombay Stock Exchange Ltd (BSE) Phiroze Jheejheebhoy Towers, Dalal Street, Mumbai - 400 001. Scrip Code - 508869 ISID,1 INE437A01024 Dear Sir, 'G' Block
16%
%) EBITDA(Post Ind AS) Margin Growth YoY(%) PAT Growth YoY(%) Healthcare Services 32,678 16% 7,806 23.9%% 14% 4,120 12.6% 2 7% o C h t l a e H o l l o p A Offline PD ^ 25,184 2
23.9%
st Ind AS) Margin Growth YoY(%) PAT Growth YoY(%) Healthcare Services 32,678 16% 7,806 23.9%% 14% 4,120 12.6% 2 7% o C h t l a e H o l l o p A Offline PD ^ 25,184 21% 1,947 7.7
14%
S) Margin Growth YoY(%) PAT Growth YoY(%) Healthcare Services 32,678 16% 7,806 23.9%% 14% 4,120 12.6% 2 7% o C h t l a e H o l l o p A Offline PD ^ 25,184 21% 1,947 7.7% 20%
12.6%
rowth YoY(%) PAT Growth YoY(%) Healthcare Services 32,678 16% 7,806 23.9%% 14% 4,120 12.6% 2 7% o C h t l a e H o l l o p A Offline PD ^ 25,184 21% 1,947 7.7% 20% ^PD:- Pharmac
7%
(%) PAT Growth YoY(%) Healthcare Services 32,678 16% 7,806 23.9%% 14% 4,120 12.6% 2 7% o C h t l a e H o l l o p A Offline PD ^ 25,184 21% 1,947 7.7% 20% ^PD:- Pharmacy Distr
21%
% 7,806 23.9%% 14% 4,120 12.6% 2 7% o C h t l a e H o l l o p A Offline PD ^ 25,184 21% 1,947 7.7% 20% ^PD:- Pharmacy Distribution Online PD^ & 24|7 3,298 13% 1 (391) Vs (1,2
7.7%
.9%% 14% 4,120 12.6% 2 7% o C h t l a e H o l l o p A Offline PD ^ 25,184 21% 1,947 7.7% 20% ^PD:- Pharmacy Distribution Online PD^ & 24|7 3,298 13% 1 (391) Vs (1,253) in Q4 FY25
20%
14% 4,120 12.6% 2 7% o C h t l a e H o l l o p A Offline PD ^ 25,184 21% 1,947 7.7% 20% ^PD:- Pharmacy Distribution Online PD^ & 24|7 3,298 13% 1 (391) Vs (1,253) in Q4 FY25 Tot
13%
ne PD ^ 25,184 21% 1,947 7.7% 20% ^PD:- Pharmacy Distribution Online PD^ & 24|7 3,298 13% 1 (391) Vs (1,253) in Q4 FY25 Total HealthCo 28,482 20% 1,556 5.5% 1,072 3.8% AHLL 4,
5.5%
ne PD^ & 24|7 3,298 13% 1 (391) Vs (1,253) in Q4 FY25 Total HealthCo 28,482 20% 1,556 5.5% 1,072 3.8% AHLL 4,895 24% 747 15.3% 58% 100 2.05% Consolidated 66,055 18% 10,109
3.8%
3,298 13% 1 (391) Vs (1,253) in Q4 FY25 Total HealthCo 28,482 20% 1,556 5.5% 1,072 3.8% AHLL 4,895 24% 747 15.3% 58% 100 2.05% Consolidated 66,055 18% 10,109 15.3% 31%
Guidance — 12 items
General Office
opening
Chennai Tel Telefax Email Website : 044 - 28290956 / 3896 / 6681 : 044 - 2829 0956 : investor.relations@apollohospitals.com : www.apollohospitals.com Apollo Hospitals Enterprise Limited Earnings Update Q4 FY26 • Disclaimer The information contained in this presentation is provided by Apollo Hospitals Enterprise Limited (the “Company”) to you solely for your reference.
General Office
opening
You acknowledge that you will be solely responsible for your own assessment of the market and the market position of the Company and that you will conduct your own analysis and be solely responsible for forming your own view of the potential future performance of the business of the Company.
General Office
opening
in Q4FY26, growth of 20% over Q4 FY25 Full stack digital healthcare platform • First-in-class AI enabled technologies including India’s first Clinical Intelligence Engine Offline Pharmacy Distribution • Serving 7,289 Operating Stores as on 31st March 2026.
General Office
opening
o Monetisation: More than doubled YoY via brand campaigns, Circle fees & ad monetisation — driving material Online EBITDA improvement over Q4 FY25.
General Office
opening
# Commissioned 4 New Hospitals in FY26 New Units pre – operative expenses or losses in Q4FY26 ` 414 mio.
General Office
opening
Average Revenue per In patient grew by 9% to `187,208 in Q4FY26 Commissioned 4 New Hospitals in FY26 New Units pre – operative expenses / losses in Q4FY26 is ` 414 mio.
General Office
opening
Total Project Cost of ~` 8,300 crs with Balance to be spent of ~`5,100crs.
General Office
opening
gross realization per patient (INR)* Network Growth – Collection Centers 822 14,898 717 20,820 733 24,535 787 724 23,840 23,908 2,108 2,215 +279 2,311 2,347 2,387 Q4 FY25 Q1 FY26 Footfalls / Day** Q2 FY26 Q3 FY26 Gross ARPV (Rs.) Q4 FY26 Q4 FY25 Q1 FY26 Q2 FY26 Q3 FY26 Q4 FY26 1.
General Office
opening
o Lowest Digital cash loss of Rs 163 Mn in Q4’FY26, reduction by Rs 634 Mn Year over year o Digital Revenue growth @ 29% excluding closure of non profitable corporate partner Apollo Telehealth (under AHEL) o Generated Revenue of Rs 144 Mn, with EBITDA of Rs 8 mn for Q4’FY26
Digital Operational Metrics
opening
o Platform GMV (20% YoY Growth) : Rs 5,281 Mn in Q4’ FY26, over Rs.
Risks & concerns — 1 flagged
o Apollo Hospitals, BG Road, Bangalore : Mucous Membrane Graft (MMG): A high-risk Stevens–Johnson Syndrome patient regained healthy eyelid function through Hospitals grafting lip mucosa, preventing blindness and restoring comfort.
General Office
Speaking time
Digital Operational Metrics
2
Regd. Office
1
General Office
1
Opening remarks
General Office
"Ali Towers" Ill Floor. #55, Greams Road, - 600 006. Chennai Tel Telefax Email Website : 044 - 28290956 / 3896 / 6681 : 044 - 2829 0956 : investor.relations@apollohospitals.com : www.apollohospitals.com Apollo Hospitals Enterprise Limited Earnings Update Q4 FY26 • Disclaimer The information contained in this presentation is provided by Apollo Hospitals Enterprise Limited (the “Company”) to you solely for your reference. This document is being given solely for your information and for your use and may not be retained by you and neither this presentation nor any part thereof may be (i) used or relied upon by any other party or for any other purpose; (ii) copied, photocopied, duplicated or otherwise reproduced in any form or by any means; or (iii) redistributed, passed on or otherwise disseminated, to any other person without the prior written consent of the Company. Although care has been taken to ensure that the information in this presentation is accurate, and that the opinions express
Digital Operational Metrics
o Platform GMV (20% YoY Growth) : Rs 5,281 Mn in Q4’ FY26, over Rs. 4,405 Mn Q4’ FY25 o IP/OP GMV remains stable year over year @ Rs 1,134 Mn for Q4’FY 26. o Consistent source for new customer acquisition (Polygon & Omni Acquisition strategy) o Continuous Improvement in quantitative parameters in Q4’ FY26 vs Q4’ FY25: o 15% YoY growth in Online Pharma Transactions o 18% YoY growth in Transacting users Digital Cash loss* (in Mn) Healthco Cash profit* (in Mn) Q4'FY25 Q1'FY26 Q2'FY26 Q3'FY26 Q4'FY26 -487 -386 79% -798 -164 -292 1,182 819 2.2X 1,426 1,662 1,783 © 2026 Apollo Hospitals Enterprise Ltd, All Rights Reserved *Cash loss/profit is EBITDA post Ind As excluding ESOP expense Q4'FY25 Q1'FY26 Q2'FY26 Q3'FY26 Q4'FY26 32 ` MioOffline Pharmacy Distribution Online Pharmacy Distribution & Apollo 247Total HealthCoTotal Revenues25,1843,29828,482EBITDA (Pre 24|7 Cost)1,9475682,515margin (%) 7.7%17.2%8.8%24/7 Operating Cost-732-732ESOP(Non Cash expense)-227-227EBITDA 1,947-3911,556margin (%) 7
Digital Operational Metrics
o Platform GMV (24% YoY Growth): Rs.20,374 Mn in FY’26, over FY’25 (16,389 Mn) o IP/OP GMV @ Rs 5,416Mn for FY’26 over FY’25 (Rs 5,000 Mn) o Consistent source for new customer acquisition (Polygon & Omni Acquisition strategy) o Continuous Improvement in quantitative parameters in FY26 vs FY25: o 26% YoY growth in Online Pharma Transactions o 27% YoY growth in Transacting users Digital Cash loss* (in Mn) Healthco Cash profit* (in Mn) FY25 FY26 -1,329 61% -3,373 120% 6,053 2,752 © 2026 Apollo Hospitals Enterprise Ltd, All Rights Reserved *Cash loss/profit is EBITDA post Ind As excluding ESOP expense FY25 FY26 33 ` MioOffline Pharmacy Distribution Online Pharmacy Distribution & Apollo 247Total HealthCoTotal Revenues95,27912,802108,081EBITDA (Pre 24|7 Cost)7,3832,1599,541margin (%) 7.7%16.9%8.8%24/7 Operating Cost-3,488-3,488ESOP(Non Cash expense)-1,178-1,178EBITDA 7,383-2,5074,875margin (%) 7.7%-4.5%EBIT3,987PBT3,434PAT (Reported)3,248Total Revenues80,14310,78790,930EBITDA (Pre 24|7 Cost)
← All transcriptsAPOLLOHOSP stock page →